Trial Profile
RDEA 594 and allopurinol in patients with gout.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2010
Price :
$35
*
At a glance
- Drugs Allopurinol (Primary) ; Allopurinol/lesinurad (Primary)
- Indications Gout
- Focus Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- 08 Nov 2010 Results reported in an Ardea Biosciences media release.
- 21 Jun 2010 New trial record
- 19 Jun 2010 Interim results presented at the Annual European Congress of Rheumatology in June 2010, according to an Ardea Biosciences media release.